2020 News
Congratulations Tetsuya Nakamura! 2020 SDB Innovation Grant Recipient
- October 13, 2020
Project:
Establishment of a Four-Dimensional Single-Cell-Resolution Developmental Atlas (4D-SCREDA) to Decode Embryonic Development and Vertebrate Evolution
Abstract:
Decoding the complete cellular trajectories of embryonic development is an ultimate goal in biology. Complete identification of cellular migration, interaction, and differentiation at the single-cell resolution can provide deeper understanding of organismal development, evolution, and etiology. However, despite the intense efforts to combine state-of-the-art techniques to analyze heterogeneity of organ precursors, a simultaneous recording of cellular migration, trajectories, and differentiation at the single-cell level in the native context of vertebrate development remains challenging. To tackle this challenge in embryology, we will build a four-dimensional single-cell-resolution developmental atlas (4D-SCREDA) of zebrafish to define developmental trajectories and specification mechanisms of individual cells during embryonic development with unprecedented resolution in a living vertebrate. As a proof-of-concept, we will apply 4D-SCREDA to early fin development, which is uniquely amenable to this strategy. The pectoral fin develops via dynamic cell migrations and differentiation. Its structure is remarkably simple, with only 500 cells, yet it consists of fundamental and conserved cell types, such as bones, blood vessels, muscles, neurons, and connective tissues. We will apply 4D-SCREDA to investigate the specification mechanisms of all cell types in appendage development and evolution that requires extensive transformation of cell fates.
The Society for Developmental Biology Innovation Grant was established in 2016 to provide seed funds for those seeking to develop innovative tools and methods with the potential to have a broad impact on the developmental biology community. This work can include devices, software, novel methods, or new reagents, but is not intended to support training or the application of existing technologies. Projects that would not necessarily be supported through other means are given preference. Graduate student, postdoctoral fellow and full SDB members are all eligible. Deadlines are December 1 and July 1. (Please note, if two grants are awarded from the December 1 deadline, then we will not be taking applications for July 1. Therefore, we strongly advise you to submit your application by the December 1 deadline). In years in which the deadline falls on a weekend, applications will be accepted until 11:59 PM (ET) of the following Monday.
See the full announcement here.
Rutgers Scientists Exploring how Fish Became Land Creatures Find Clues at Iconic Manhattan Museum
- September 10, 2020
A world-renowned collection helps genetics team piece together the story
The American Museum of Natural History was teeming with busloads of students, tourist groups, and parents with toddlers in tow.
Tetsuya Nakamura, a Rutgers University professor of genetics, fit right into the mix. But rather than gaze at the T-Rex skeleton or marvel at the iconic blue whale model, Nakamura and four members of his research team moved away from the public exhibits into an area behind closed doors. In a brightly-lit laboratory, they stood arrayed around a large stainless steel table, examining sample after sample of dead fish.
“We’re focusing on skulls and fins today,” Nakamura said.
Nakamura had hoped that the visit last year would be the first of many his team would make to the museum. But the COVID-19 pandemic put his plans on hold. Now that the museum has reopened to the public at 25 percent capacity, Nakamura is hoping that soon, with safety protocols in place, his team can return.
Nakamura’s research explores the genetics that helped drive the transformation some 400 million years ago in which fish evolved into tetrapods—four-limbed land creatures with spines, including birds, reptiles, and humans. Nakamura came to Rutgers from the University of Chicago, where he worked on a breakthrough study showing how the same two genes control the embryonic development of both the fin rays of fish and the hands and fingers of humans, despite the very different bone structure.
“If you want to understand this big change from fish to tetrapod, we have to go back to embryonic development,” he says. “So my interests are really an intersection of developmental and evolutionary biology.”
Nakamura was drawn to Rutgers in 2017 by the size and scope of the Department of Genetics in the School of Arts and Sciences. He says the department’s expertise in genomics and computational genetics and its research-driven culture made it the ideal place to continue his work and find accomplished colleagues and eager students.
Genetics department Chair Tara Matise says Nakamura is a great fit. “The scope of research here requires a range of settings, from traditional wet labs to computer-driven dry labs, to hybrids that do both," she said."Tetsuya's interests in evolution and development are complemented by our strengths in computational genetics."
Members of Nakamura’s team are already advancing his work in new directions. Thomas Wood, who graduated in 2020, uses gene editing techniques to understand how fish may have evolved into mammals with necks. By “turning off” certain genes, he says, fish began to lose the solid connection that fuses the skull to the body, creating a gap in which a neck could develop. Wood has been accepted into the Genetics and Development doctoral program at Columbia University.
Coming to Rutgers provided another advantage for Nakamura: close proximity to research facilities such as the Museum of Natural History. The museum’s fish, or ichthyological collection, contains nearly three million specimens, with samples that go back hundreds of years to the present. Though not part of the museum’s public exhibits, the collection is open to the research community, drawing scholars from around the world who are studying everything from taxonomy to ecology to evolution.
“You can come here and find out what was living at Point X a hundred years ago and you could compare that to a sample collected today from the same place,” says Scott A. Schaefer, the museum’s Dean of Science for Collections. “You can perform a scan and compare those two exemplars and how the morphology has changed.”
Indeed, the collection provides Nakamura’s team a rich record of fish diversity from various time frames. The Rutgers researchers aim to take CT scans of the specimens to create images of the bones, blood vessels, and soft tissues that they can compare to the genetically modified samples they create in the Rutgers lab.
“It gives the ability to compare the size, shape, and structure and then determine how much our genetic manipulation tells us about real evolution,” Nakamura says.
During the first visit, the Rutgers team looked at a ray that was acquired near Japan; a liparis, or snail fish collected in Siberia; and sea robins from Sandy Hook. While Nakamura focused on the fin-to-hand transition, Wood and post-doc Shunsuke Mori studied the fish skulls.
“Understanding the evolutionary trends of the skull will give us a more holistic picture of our own skull development,” Wood says. “And that can be taken in all sorts of directions.”
Nakamura plans to return often to the museum and bring more of his students.
Seizures During Menstrual Cycle Lined to Drug-Resistant Epilepsy
- August 26, 2020
Study finds surprising connection in some women with genetic generalized epilepsy
More frequent seizures during the menstrual cycle in women with genetic generalized epilepsy have been linked for the first time to drug-resistant epilepsy, when anti-seizure medications don’t work, according to a Rutgers coauthored study that may help lead to tailored treatments.
Women with a form of genetic generalized epilepsy called catamenial epilepsy – when seizure frequency increases during their menstrual cycle – were nearly four times more likely to have drug-resistant epilepsy than women who experience no changes in frequency, according to the study in the journal Neurology. This association was found in two independent samples.
“Typically, genetic generalized epilepsy is thought to respond better to anti-seizure medications than focal epilepsy. However, previous studies suggest a minority of individuals, between 18 percent and 36 percent, with genetic generalized epilepsy do not respond well to these medications,” said senior author Gary A. Heiman, an associate professor in the Department of Genetics in the School of Arts and Sciences at Rutgers University–New Brunswick. “It is unclear why seizures in these individuals do not respond well, and we sought to investigate why. We found a surprising association between women’s menstrual cycle and those with drug-resistant genetic generalized epilepsy. Understanding the reasons for this association could lead to alternative, personalized treatment options for at least some patients.”
In generalized epilepsy, seizures begin on both sides of the brain, while focal epilepsy seizures start in only one part of the brain.
In 2015, about 3.4 million people, including 470,000 children, had epilepsy in the United States, according to the U.S. Centers for Disease Control and Prevention. Anti-seizure drugs limit the spread of seizures in the brain and work for about two-thirds of people with epilepsy. Other options include surgery.
The study included 589 patients with or without drug-resistant genetic generalized epilepsy at Columbia Comprehensive Epilepsy Center and 66 patients at Yale Comprehensive Epilepsy Center. The goal was to develop and validate a model for predicting generalized epilepsy that resists drug treatment.
Such models may allow healthcare professionals to identify patients who may benefit from more aggressive or different kinds of treatment.
“Women whose seizures increase during their menstrual cycle and have drug-resistant genetic generalized epilepsy may represent a homogeneous group with a specific cause,” Heiman said. “Genetic and treatment studies of these women could uncover the reason, and tailored treatment could be developed. Although our study sample is one of the largest to date and found in two independent samples, further investigation using larger sample sizes is required.”
Suzanne Thornton, who earned a doctorate at Rutgers and is now at Swarthmore University, contributed to the study. Coauthors include scientists at Columbia University Medical Center, University of Miami, Yale University, University of Oxford, Free University of Brussels, Monash University, The Royal Melbourne Hospital, The University of Melbourne and Alfred Health.
Dr. Gary Heiman Authored and Jessica Joines and Christine Seymour Co-authored a Paper on Tic Disorders and Genetic Counseling
- August 11, 2020
Congratulations to Dr. Gary Heiman, on the recent publication of his article regarding empiric recurrence risk estimates for chronic tic disorders and implications for genetic counseling. Jessica Rispoli Joines, and Assistant Program Director, Christine Seymour, were co-authors as well.
Dr. Jay Tischfield and Attorney Fred Tromberg Discuss COVID-19
- July 17, 2020
Listen to Dr. Jay Tischfield, Executive Director of the Human Genetics Institute of New Jersey, interview on Attorney Fred Tromberg’s show, Life, The Law & Legal Issues on PURE Radio (103.7 FM & 1320 AM), Jacksonville, Florida’s Christian Station. Dr. Tischfield and Attorney Tromberg discuss COVID19 and the pandemic. They take a look at the science and discuss the effect of the virus on our country. They also talk about testing, tracing and working toward a vaccine as well as therapeutics.
Fred Tromberg is a Florida Bar Board Certified Civil Trial Attorney with over 40 years of experience as a lawyer practicing in Jacksonville and Northeast Florida. The show broadcasted in July 2020 with 30,000 listeners by radio and another 1,000 or so on pureradiojax.org which is simulcast worldwide.